https://www.selleckchem.com/pr....oducts/bi-1015550.ht
kelihood of achieving normal olfaction, while NP and previous ESS decreased those odds. ESS improved olfactory metrics and restored olfactory function in approximately 50% of patients with CRS to that of healthy controls. Concurrent septoplasty increased the likelihood of achieving normal olfaction, while NP and previous ESS decreased those odds. Fixed dose combinations (FCs) represent a potentially valuable treatment strategy in glaucoma management. Fixed combinations not only improve adherence by reducing the medication burden, but
Like
Comment
Share
